The Quantase R Phenylalanine Assay, an enzymatic/colorimetric method for the determination of phenylalanine (Phe) in dried bloodspots, was evaluated for the neonatal screening on PKU. The within run variation (N=12) for bloodspot samples with 0.15, 0.29 and 0.53 mmol/l was 10%, 5% and 5%, respectively. The between run variation (N=56) for bloodspot samples with 0.38 and 0.96 mmol/l was 9% and 8%, respectively. The mean concentration and standarddeviation in 33630 bloodspot samples was 0.077 +- 0.025 mmol/l (%CV=32%). The measured Phe-concentration was elevated (>=0.24 mmol/l) in 13 samples (0.039%). Reanalysis of these samples, in the same bloodspots, revealed a Phe-concentration of <0.12 mmol/l in 6 samples. These 6 samples were also foun...
Phenylketonuria (PKU) is commonly included in the newborn screening panel of most countries, with va...
Monitoring phenylalanine (Phe) concentrations is critical for the management of phenylketonuria (PKU...
Measurement of plasma and dried blood spot (DBS) phenylalanine (Phe) is key to monitoring patients w...
The Quantase R Phenylalanine Assay, an enzymatic/colorimetric method for the determination of phenyl...
Phenylketonuria (PKU) was the first disease to be identified by the newborn screening (NBS) program....
Summary: A fluorometric assay in microtitre plates for the screening of phenylketonuria was evaluate...
Phenylketonuria (PKU) is caused by deficient activity of phenylalanine hydroxylase (PAH), responsibl...
Abstract Phenylketonuria (PKU) is caused by deficient activity of phenylalanine hydroxylase (PAH), r...
Phenylalanine (Phe) is the most reliable indicator for the diagnosis of phenylketonuria (PKU). The p...
The fluorometric analysis of phenylalanine described by McCaman and Robins has been adapted to autom...
Introduction: Inborn errors of metabolism (IEM) are a collective group of rare genetic disorders tha...
Background: Reliable measurement of phenylalanine (Phe) is a prerequisite for adequate follow-up of ...
Graduation date: 2016Phenylketonuria (PKU) is a genetic inborn metabolic disorder which inhibits\ud ...
We have developed a reversed-phase liquid-chromatograph-ic procedurefor simultaneouslydetermining ph...
tem for the simultaneous measurement of phenytalanine and galactose from blood specimens on filter-p...
Phenylketonuria (PKU) is commonly included in the newborn screening panel of most countries, with va...
Monitoring phenylalanine (Phe) concentrations is critical for the management of phenylketonuria (PKU...
Measurement of plasma and dried blood spot (DBS) phenylalanine (Phe) is key to monitoring patients w...
The Quantase R Phenylalanine Assay, an enzymatic/colorimetric method for the determination of phenyl...
Phenylketonuria (PKU) was the first disease to be identified by the newborn screening (NBS) program....
Summary: A fluorometric assay in microtitre plates for the screening of phenylketonuria was evaluate...
Phenylketonuria (PKU) is caused by deficient activity of phenylalanine hydroxylase (PAH), responsibl...
Abstract Phenylketonuria (PKU) is caused by deficient activity of phenylalanine hydroxylase (PAH), r...
Phenylalanine (Phe) is the most reliable indicator for the diagnosis of phenylketonuria (PKU). The p...
The fluorometric analysis of phenylalanine described by McCaman and Robins has been adapted to autom...
Introduction: Inborn errors of metabolism (IEM) are a collective group of rare genetic disorders tha...
Background: Reliable measurement of phenylalanine (Phe) is a prerequisite for adequate follow-up of ...
Graduation date: 2016Phenylketonuria (PKU) is a genetic inborn metabolic disorder which inhibits\ud ...
We have developed a reversed-phase liquid-chromatograph-ic procedurefor simultaneouslydetermining ph...
tem for the simultaneous measurement of phenytalanine and galactose from blood specimens on filter-p...
Phenylketonuria (PKU) is commonly included in the newborn screening panel of most countries, with va...
Monitoring phenylalanine (Phe) concentrations is critical for the management of phenylketonuria (PKU...
Measurement of plasma and dried blood spot (DBS) phenylalanine (Phe) is key to monitoring patients w...